Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

NCT03321656 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

78

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease

Interventions

DRUG: Tacrolimus
DRUG: Envarsus XR

Sponsor

Roberto Gedaly

Collaborators

[object Object]